Journal
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
Volume 30, Issue 4, Pages 765-769Publisher
SPRINGER
DOI: 10.1007/s00270-007-9037-2
Keywords
radiofrequency ablation; renal cell carcinoma
Ask authors/readers for more resources
We performed percutaneously radiofrequency (RF) ablation of 5 renal cell carcinomas (mean diameter 26 +/- 15 mm) with computed-tomography (CT) fluoroscopic guidance using the transhepatic route. The RF electrode was successfully advanced into all tumors. RF ablation caused one minor complication (small asymptomatic perirenal hematoma); no major complications occurred. The follow-up contrast-enhanced CT images showed no local tumor progression of any tumors in a median period of 10 months (range 3-14 months). In conclusion, it seems that this transhepatic approach is safe and can be an alternative method for electrode insertion during RF ablation of selected renal tumors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available